Home » Topics » BioWorld Science

BioWorld Science
RSS

Bristol-Myers Squibb to develop Toray antiplatelet agent in the U.S. and Canada

Oct. 11, 1996

Fujisawa's antiplatelet agent in clinical trials

Oct. 11, 1996

Integrin receptor antagonists described by SKB

Oct. 11, 1996

Antiplatelet fibrinogen antagonists from Yamanouchi

Oct. 11, 1996

Fibrinogen antagonist research continues at Merck & Co.

Oct. 11, 1996

Significant progress in cardiovascular R&D at Yamanouchi

Oct. 11, 1996

BTG licenses drug for cardiac arrest

Oct. 11, 1996

New approval for carvedilol in congestive heart failure

Oct. 11, 1996

Clinical results with adenosine agonist

Oct. 11, 1996

Lynx licenses antisense compound for restenosis to Schwarz

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...